Ependymoma epidemiology and demographics

Jump to: navigation, search

Ependymoma Microchapters

Home

Patient Information

Overview

Classification

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Differentiating Ependymoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ependymoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ependymoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ependymoma epidemiology and demographics

CDC on Ependymoma epidemiology and demographics

Ependymoma epidemiology and demographics in the news

Blogs on Ependymoma epidemiology and demographics</small>

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Ependymoma epidemiology and demographics

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Prevalence

Age

  • Their occurrence seems to peak at age 5 years and then again at age 34.
  • Subependymoma usually affects people over 40 years of age

Gender

  • Subependymoma more often affects men than women.

References


Linked-in.jpg